151 related articles for article (PubMed ID: 24284041)
21. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
[TBL] [Abstract][Full Text] [Related]
23. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
Sharifi Z; Faranoush M; Mohseni A; Rostami S; Ramzi M; Sharifi MJ
Per Med; 2019 Nov; 16(6):479-490. PubMed ID: 31647372
[No Abstract] [Full Text] [Related]
25. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
26. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
Batar B; Güven M; Bariş S; Celkan T; Yildiz I
Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
[TBL] [Abstract][Full Text] [Related]
27. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Lin B; Chen J; Tang F; Huang G
PLoS One; 2012; 7(9):e43431. PubMed ID: 23028453
[TBL] [Abstract][Full Text] [Related]
28. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia.
Shi JY; Ren ZH; Jiao B; Xiao R; Yun HY; Chen B; Zhao WL; Zhu Q; Chen Z; Chen SJ
Int J Cancer; 2011 Jan; 128(1):233-8. PubMed ID: 20232390
[TBL] [Abstract][Full Text] [Related]
29. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG).
Güven M; Unal M; Batar B; Eroğlu E; Devarnoğlu K; Tamçelik N; Uçar D; Sarici A
Mol Vis; 2007 Jan; 13():12-7. PubMed ID: 17242676
[TBL] [Abstract][Full Text] [Related]
31. Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.
Costa S; Pinto D; Pereira D; Vasconcelos A; Afonso-Lopes C; Osório T; Lopes C; Medeiros R
Cancer Lett; 2007 Feb; 246(1-2):324-30. PubMed ID: 16677755
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression and the Lys751Gln polymorphism of the XPD gene are associated with extreme longevity.
Polosak J; Roszkowska-Gancarz M; Kurylowicz A; Owczarz M; Dobosz P; Mossakowska M; Szybinska A; Puzianowska-Kuznicka M
Biogerontology; 2010 Jun; 11(3):287-97. PubMed ID: 19707883
[TBL] [Abstract][Full Text] [Related]
33. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
Gangwar R; Ahirwar D; Mandhani A; Mittal RD
Urology; 2009 Mar; 73(3):675-80. PubMed ID: 19041121
[TBL] [Abstract][Full Text] [Related]
34. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population.
Radwan WM; Elbarbary HS; Alsheikh NM
Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768
[TBL] [Abstract][Full Text] [Related]
35. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
36. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
37. Association of xeroderma pigmentosum group D (Asp312Asn, Lys751Gln) and cytidine deaminase (Lys27Gln, Ala70Thr) polymorphisms with outcome in Chinese non-small cell lung cancer patients treated with cisplatin-gemcitabine.
Zhou M; Ding YJ; Feng Y; Zhang QR; Xiang Y; Wan HY
Genet Mol Res; 2014 Apr; 13(2):3310-8. PubMed ID: 24841663
[TBL] [Abstract][Full Text] [Related]
38. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.
Yan Y; Liang H; Light M; Li T; Deng Y; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1907-15. PubMed ID: 24101192
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma.
Dybdahl M; Vogel U; Frentz G; Wallin H; Nexø BA
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):77-81. PubMed ID: 9950243
[TBL] [Abstract][Full Text] [Related]
40. Association of XPD Asp312Asn polymorphism and response to oxaliplatin-based first-line chemotherapy and survival in patients with metastatic colorectal cancer.
Liu Z; Kong J; Kong Y; Cai F; Xu X; Liu J; Wang S
Adv Clin Exp Med; 2019 Nov; 28(11):1459-1468. PubMed ID: 31756062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]